Back
Akari Therapeutics PLC Stock Price Chart
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Buy
58
AKTX
Akari Therapeutics PLC
Last Price:
3.10
Seasonality Move:
-14.85%
7 Day Trial
ALL ACCESS PASS
$
7
10 minutes on Tuesday - $1,270 by Friday?
Click here to discover how this "odd" trade could double your money each week.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Akari Therapeutics PLC Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.27 | Sell |
| 20-day SMA: | 3.48 | Sell |
| 50-day SMA: | 3.6 | Sell |
| 200-day SMA: | 2.61 | Buy |
| 8-day EMA: | 3.26 | Sell |
| 20-day EMA: | 3.39 | Sell |
| 50-day EMA: | 3.37 | Sell |
| 200-day EMA: | 3.18 | Buy |
Akari Therapeutics PLC Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 42.71 | Sell |
| Chaikin Money Flow: | 617 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.27 - 3.73) | Sell |
| Bollinger Bands (100): | (2.08 - 3.8) | Buy |
Akari Therapeutics PLC Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Akari Therapeutics PLC Stock
Is Akari Therapeutics PLC Stock a Buy?
- Akari Therapeutics PLC share price is 3.22 while AKTX 8-day simple moving average is 3.27, which is a Sell signal.
- The stock price of AKTX is 3.22 while Akari Therapeutics PLC 20-day SMA is 3.48, which makes it a Sell.
- Akari Therapeutics PLC 50-day simple moving average is 3.60 while AKTX share price is 3.22, making it a Sell technically.
- AKTX stock price is 3.22 and Akari Therapeutics PLC 200-day simple moving average is 2.61, creating a Buy signal.
AKTX Technical Analysis vs Fundamental Analysis
Buy
58
Akari Therapeutics PLC (AKTX)
is a Buy
Is Akari Therapeutics PLC a Buy or a Sell?
-
Akari Therapeutics PLC stock is rated a Buy
The current Akari Therapeutics PLC [AKTX] share price is $3.22. The Score for AKTX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
Akari Therapeutics PLC Stock Info
Market Cap:
38.49M
Price in USD:
3.22
Share Volume:
617
Akari Therapeutics PLC 52-Week Range
52-Week High:
4.40
52-Week Low:
1.08
Buy
58
Akari Therapeutics PLC (AKTX)
is a Buy
Akari Therapeutics PLC Share Price Forecast
-
What is the Akari Therapeutics PLC stock price today?
The Akari Therapeutics PLC stock price is 3.22 USD today. -
Will AKTX stock go up or go down?
Akari Therapeutics PLC> share price is forecast to RISE/FALL based on technical indicators -
Is Akari Therapeutics PLC overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akari Therapeutics PLC is not overvalued.
Is Akari Therapeutics PLC Stock a Buy?
- Akari Therapeutics PLC share price is 3.22 while AKTX 8-day exponential moving average is 3.26, which is a Sell signal.
- The stock price of AKTX is 3.22 while Akari Therapeutics PLC 20-day EMA is 3.39, which makes it a Sell.
- Akari Therapeutics PLC 50-day exponential moving average is 3.37 while AKTX share price is 3.22, making it a Sell technically.
- AKTX stock price is 3.22 and Akari Therapeutics PLC 200-day simple moving average is 3.18, creating a Buy signal.
Fundamental Analysis of Akari Therapeutics PLC
Is Akari Therapeutics PLC a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Akari Therapeutics PLC
Should I short Akari Therapeutics PLC stock?
- AKTX Moving Average Covergence Divergence (MACD) indicator is -0.1, suggesting Akari Therapeutics PLC is a Sell
- Akari Therapeutics PLC Relative Strength Index (RSI) is 42.71, which suggest Akari Therapeutics PLC is oversold
- The Bollinger Bands (25) for Akari Therapeutics PLC is (3.27 - 3.73), which suggest Akari Therapeutics PLC is a Buy
- The Bollinger Bands (100) for Akari Therapeutics PLC is (2.08 - 3.8), which suggest Akari Therapeutics PLC is a Buy
* Akari Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.